
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7346881
[patent_doc_number] => 20040192656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Methods and compositions for the treatment of human and animal cancers'
[patent_app_type] => new
[patent_app_number] => 10/818613
[patent_app_country] => US
[patent_app_date] => 2004-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13451
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10818613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/818613 | Methods and compositions for the treatment of human and animal cancers | Apr 5, 2004 | Abandoned |
Array
(
[id] => 7530494
[patent_doc_number] => 07842716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Treating vascular events with statins by inhibiting PAR-1 and PAR-4'
[patent_app_type] => utility
[patent_app_number] => 10/811563
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8975
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842716.pdf
[firstpage_image] =>[orig_patent_app_number] => 10811563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/811563 | Treating vascular events with statins by inhibiting PAR-1 and PAR-4 | Mar 28, 2004 | Issued |
Array
(
[id] => 7319348
[patent_doc_number] => 20040225018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Pharmaceutical compositions of CETP inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/802220
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22859
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802220 | Pharmaceutical compositions of CETP inhibitors | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7250058
[patent_doc_number] => 20050272644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Method for increasing therapeutic gain in radiotherapy and chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 10/798119
[patent_app_country] => US
[patent_app_date] => 2004-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 9218
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10798119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/798119 | Method for reducing radiation-induced normal tissue damage | Mar 10, 2004 | Issued |
Array
(
[id] => 7326775
[patent_doc_number] => 20040253205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'c-Kit kinase inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/797903
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8348
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10797903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/797903 | c-Kit kinase inhibitor | Mar 9, 2004 | Issued |
Array
(
[id] => 7276415
[patent_doc_number] => 20040235866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Lymphocytic activation inhibitor and remedial agent for autoimmune disease'
[patent_app_type] => new
[patent_app_number] => 10/488654
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5616
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488654
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488654 | Lymphocytic activation inhibitor and remedial agent for autoimmune disease | Mar 3, 2004 | Abandoned |
Array
(
[id] => 5154958
[patent_doc_number] => 20070037841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/547234
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6548
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547234 | Inhibitors | Feb 25, 2004 | Abandoned |
Array
(
[id] => 7202031
[patent_doc_number] => 20050165242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Process for the preparation of amorphous atorvastatin calcium'
[patent_app_type] => utility
[patent_app_number] => 10/771383
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2685
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165242.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771383 | Process for the preparation of amorphous atorvastatin calcium | Feb 4, 2004 | Abandoned |
Array
(
[id] => 5890169
[patent_doc_number] => 20060276527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Combination therapies for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/543228
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20614
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276527.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543228
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543228 | Combination therapies for the treatment of cancer | Jan 15, 2004 | Abandoned |
Array
(
[id] => 5632334
[patent_doc_number] => 20060148804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Pde4 inhibitors for the treatment of neoplasms of lymphoid cells'
[patent_app_type] => utility
[patent_app_number] => 10/542088
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7928
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542088 | Pde4 inhibitors for the treatment of neoplasms of lymphoid cells | Jan 13, 2004 | Abandoned |
Array
(
[id] => 5649749
[patent_doc_number] => 20060135484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/540667
[patent_app_country] => US
[patent_app_date] => 2004-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76178
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135484.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540667 | Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators | Jan 6, 2004 | Abandoned |
Array
(
[id] => 5801562
[patent_doc_number] => 20060035942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Fungicidal combinations of active substances'
[patent_app_type] => utility
[patent_app_number] => 10/518669
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2161
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518669 | Fungicidal combinations of active substances | Nov 5, 2003 | Abandoned |
Array
(
[id] => 5880473
[patent_doc_number] => 20060029555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Compositions and methods for prevention of photoaging'
[patent_app_type] => utility
[patent_app_number] => 10/533353
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1583
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533353
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533353 | Compositions and methods for prevention of photoaging | Oct 28, 2003 | Abandoned |
Array
(
[id] => 7412259
[patent_doc_number] => 20040106683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Uses of benzylideneamino guanidines as ligands to the melnocortin receptors'
[patent_app_type] => new
[patent_app_number] => 10/472768
[patent_app_country] => US
[patent_app_date] => 2003-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2854
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472768
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472768 | Uses of benzylideneamino guanidines as ligands to the melnocortin receptors | Oct 5, 2003 | Abandoned |
Array
(
[id] => 7424294
[patent_doc_number] => 20040208843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Cosmetic composition comprising an exogenous ligand-receptor system adsorbed or covalently attached to keratin materials, and hair treatment using this composition or constituent elements thereof'
[patent_app_type] => new
[patent_app_number] => 10/667435
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13366
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208843.pdf
[firstpage_image] =>[orig_patent_app_number] => 10667435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/667435 | Cosmetic composition comprising an exogenous ligand-receptor system adsorbed or covalently attached to keratin materials, and hair treatment using this composition or constituent elements thereof | Sep 22, 2003 | Abandoned |
Array
(
[id] => 5801635
[patent_doc_number] => 20060035971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Blood fluidity improving agent'
[patent_app_type] => utility
[patent_app_number] => 10/533660
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5172
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533660 | Blood fluidity improving agent | Sep 2, 2003 | Abandoned |
Array
(
[id] => 5711106
[patent_doc_number] => 20060052451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Method'
[patent_app_type] => utility
[patent_app_number] => 10/526025
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12313
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052451.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526025 | Method | Aug 28, 2003 | Abandoned |
Array
(
[id] => 5850533
[patent_doc_number] => 20060233724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Medicinal composition for peridontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/526014
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6230
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233724.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526014 | Medicinal composition for peridontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient | Aug 27, 2003 | Abandoned |
Array
(
[id] => 4698896
[patent_doc_number] => 20080221080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias'
[patent_app_type] => utility
[patent_app_number] => 10/569708
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1371
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569708 | Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias | Aug 24, 2003 | Abandoned |
Array
(
[id] => 5777459
[patent_doc_number] => 20060106099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Novel inhibitors of ubiquitin isopeptidases'
[patent_app_type] => utility
[patent_app_number] => 10/521570
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14581
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106099.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521570
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521570 | Novel inhibitors of ubiquitin isopeptidases | Jul 17, 2003 | Abandoned |